CGA and B-cell chronic lymphocytic leukemia: Furthermore, using the mouse models, we show that physiologically relevant concentrations of full-length CgA and VS-1, but not of fragments lacking the C-terminal region, can reduce the trafficking of CLL cells in blood and tissues and delay CLL progression.